Compare · ACST vs HUGE
ACST vs HUGE
Side-by-side comparison of Acasti Pharma Inc. (ACST) and FSD Pharma Inc. (HUGE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ACST and HUGE operate in Biotechnology: Pharmaceutical Preparations (Health Care), so they compete in similar markets.
- HUGE is the larger of the two at $55.5M, about 1.1x ACST ($49.6M).
- ACST has more recent analyst coverage (2 ratings vs 0 for HUGE).
- Company
- Acasti Pharma Inc.
- FSD Pharma Inc.
- Price
- $3.59+9.79%
- $0.09-8.17%
- Market cap
- $49.6M
- $55.5M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Biotechnology: Pharmaceutical Preparations
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 0
- 0
- Recent ratings
- 2
- 0
Acasti Pharma Inc.
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia; and TRILOGY that is in Phase III to evaluate the safety and efficacy of CaPre in patients with sHTG. The company was incorporated in 2002 and is headquartered in Laval, Canada.
FSD Pharma Inc.
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD 201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also develops drugs for the treatment of pain, inflammation, and neurological disorders. It has license agreements with Epitech Group SpA.; and with Innovet Italia S.R.L. to develop veterinary drugs for the treatment of gastro-intestinal diseases in dogs and cats. The company was founded in 1998 and is headquartered in Toronto, Canada.
Latest ACST
- Grace Therapeutics to Participate in Upcoming Investor Events January 2025
- Grace Therapeutics to Exhibit at the American Society of Health-System Pharmacists Conference
- Acasti Pharma Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- Acasti Pharma Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Acasti Announces Corporate Name Change to Grace Therapeutics, Inc.
- SEC Form EFFECT filed by Acasti Pharma Inc.
- SEC Form EFFECT filed by Acasti Pharma Inc.
- SEC Form S-8 filed by Acasti Pharma Inc.
- SEC Form S-8 POS filed by Acasti Pharma Inc.
- SEC Form S-8 POS filed by Acasti Pharma Inc.
Latest HUGE
- Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari
- Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhari at the Court of Appeal for Ontario
- Quantum Biopharma in Court With Dr. Raza Bokhari on January 24, 2025 Seeking a Court Order to Declare Him to Be a Vexatious Litigant and Other Litigation Updates
- Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Alleged Spoofing/Stock Price Manipulation
- Quantum Biopharma Announces Intention to Complete Debt Settlements and Provides Corporate Update
- SEC Form 6-K filed by FSD Pharma Inc.
- Amendment: SEC Form 6-K/A filed by FSD Pharma Inc.
- SEC Form 6-K filed by FSD Pharma Inc.
- SEC Form 6-K filed by FSD Pharma Inc.
- FSD Pharma Provides Update on its Investment in Celly Nutrition Corp. Who Secures Additional Financing to Launch unbuzzd(TM) Stick Packs this Month - Created by a World-Class Pharmaceutical Research & Development Team